KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Goodwill (2021 - 2025)

Fulgent Genetics' Goodwill history spans 5 years, with the latest figure at $25.1 million for Q4 2025.

  • For Q4 2025, Goodwill rose 13.72% year-over-year to $25.1 million; the TTM value through Dec 2025 reached $25.1 million, up 13.72%, while the annual FY2025 figure was $25.1 million, 13.72% up from the prior year.
  • Goodwill for Q4 2025 was $25.1 million at Fulgent Genetics, roughly flat from $25.1 million in the prior quarter.
  • Across five years, Goodwill topped out at $143.0 million in Q4 2022 and bottomed at $22.1 million in Q4 2023.
  • The 5-year median for Goodwill is $24.1 million (2021), against an average of $50.3 million.
  • The largest annual shift saw Goodwill surged 181.01% in 2022 before it tumbled 84.58% in 2023.
  • A 5-year view of Goodwill shows it stood at $50.9 million in 2021, then soared by 181.01% to $143.0 million in 2022, then crashed by 84.58% to $22.1 million in 2023, then changed by 0.0% to $22.1 million in 2024, then rose by 13.72% to $25.1 million in 2025.
  • Per Business Quant, the three most recent readings for FLGT's Goodwill are $25.1 million (Q4 2025), $25.1 million (Q3 2025), and $22.1 million (Q2 2025).